Home Newsfeeds Piper Sandler Maintains Neutral on Itron, Lowers Price Target to $50

Piper Sandler Maintains Neutral on Itron, Lowers Price Target to $50

Piper Sandler analyst Pearce Hammond maintains Itron (NASDAQ:ITRI) with a Neutral and lowers the price target from $51 to $50.

byBenzinga Newsdesk

July 19, 2022

1 minute read

Piper Sandler analyst Pearce Hammond maintains Itron (NASDAQ:ITRI) with a Neutral and lowers the price target from $51 to $50.

RingCentral On Track To Retire $1.6B Debt In FY26 With Strong FCF Focus: Analyst Forecasts

By Nabaparna Bhattacharya

August 8, 3:45 PM

Needham analyst Ryan Koontz reiterated a Buy rating on RingCentral, Inc (NYSE: RNG),

RNG

Crypto ‘An Outsized Piece Of The Scams And Problems’ In Markets: Gary Gensler

By Murtuza Merchant

May 7, 10:30 AM

Pointing out the disproportionate amount of fraud and scams within the relatively small crypto sector compared to its size in the broader market, SEC chair Gary Gensler on Tuesday highlighted the agency's focus amid the ma

COIN

Elastic Stock Soars After-Hours On Q2 Earnings Beat, Outlook

By Ryan Gustafson

November 30, 6:30 PM

Elastic NV (NYSE: ESTC) shares are trading higher in Thursday's after-hours session after the company reported better-than-expected second-quarter financial results and issued

ESTC

STAAR Surgical Stock Tumbles After Q2 Earnings: Here’s Why

By Vandana Singh

August 3, 11:34 AM

STAAR Surgical Company's (NASDAQ: STAA) Q2 sales reached $92.3 million, up 14% Y/Y, driven by ICL sales growth of 19% and ICL unit growth of 21%, missing the

STAA

Piper Sandler Maintains Neutral on Itron, Lowers Price Target to $50

Related Posts

RingCentral On Track To Retire $1.6B Debt In FY26 With Strong FCF Focus: Analyst Forecasts

Crypto ‘An Outsized Piece Of The Scams And Problems’ In Markets: Gary Gensler

Elastic Stock Soars After-Hours On Q2 Earnings Beat, Outlook

STAAR Surgical Stock Tumbles After Q2 Earnings: Here’s Why